The Community has taken action against the influenza A (H1N1) pandemic both internally and externally.
For a shining success story of the power of immunisation and the need for development aid in general, look no further than the example of measles in Africa, where, largely due to vaccination programmes, deaths from the disease fell from 90% between 2000 and 2006.
The pneumococcal AMC offers an unprecedented opportunity for countries to protect their children from this preventable killer.
Yet the sad fact is that, of the 71 countries that are eligible, fewer than 20 have applied for AMC funding that will save so many lives.
